It turns out, they like us, or so they say. Biomedical researchers should take note that for the second year in a row, U.S. Senate appropriators have declared funding the National Institutes of Health a...


When presenting to the Congressional Biomedical Research Caucus (CBRC), you want to best represent the work...

CBRC Briefings

Improving the Quality and Efficiency of Health Care for Older Americans - 6/17/09


Dr. Chad Boult
Johns Hopkins School of Public Health


Dr. Chad Boult and his team have created a new model of comprehensive health care, called Guided Care, which targets people living with multiple chronic conditions, the typical high-cost Medicare beneficiaries. His plan is based on the simple premise that a patient’s “care plan” is well coordinated, and patients and families are involved in and educated about the care plan. Guided Care is based on the simple notion that one trained professional should guide all aspects of care, uniting the patient, the family, and the medical team.


Improving the US's Innovation Ecology - 6/10/09


Dr. William Wulf
University of Virginia


There is an ecology of interacting laws, regulations and institutions that are intended to support innovation – a traditional strength of the U.S. Unfortunately, the current elements of that ecology were designed a long time ago for the technologies that existed at that time and are not well suited to the technologies of today and tomorrow. This talk explores the nature of the problem and some possible solutions.

Using Genes to Redefine Disease - 6/5/09


Dr. Atul Butte
Stanford University


Dr. Atul Butte of Stanford University is at the forefront of the nascent field of translational bioinformatics—a field that seeks to create new diagnostics and therapeutics from genome-era information and data. Here he highlights how new uses for publicly available data have enabled us to ask new questions, including rethinking the nature of disease. Dr. Butte gathers this data on gene activity for scores of diseases. He is looking not at the symptoms or physiological measurements of disease, but at their genetic underpinnings. He performs statistical analyses to map disease based on similarities in their patterns of gene activity. Dr. Butte is able to show how using genes to redefine disease enables the discovery of new causes for disease, suggests novel roles for drugs in the treatment of disease, and, for the first time, allows us to probe the inner commonality across diseases that previously seemed dissimilar.